Irritable Bowel Syndrome Trial, Recruiting (NCT07309601)

Irritable Bowel Syndrome Trial, Recruiting NCT07309601 Sponsor: Region Skane Condition: Irritable Bowel Syndrome

Printed from Voxsanity (voxsanity.com.au) — NCT07309601 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Irritable Bowel Syndrome

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who have been diagnosed with irritable bowel syndrome (IBS)
People who have already had genetic testing related to genes that control the production of certain digestive enzymes (called sucrase-isomaltase), as part of a previous study involving a low-starch and low-sugar diet (called SSRD) or a related multi-centre study

Who may not be able to join:

People who have been diagnosed with inflammatory bowel disease, coeliac disease, bile salt malabsorption, gastroenteritis, or problems with how the gut moves food through the body
People who have a severe food allergy
People who have a serious heart, lung, cardiovascular, or mental health condition, or a serious illness such as cancer
People who currently have an eating disorder
People who are pregnant
People who have recently had major surgery on their digestive system
People who have an addiction to alcohol or drugs

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Cecilia Kennbäck, Registered Nurse, Department of Internal Medicine, Skåne University Hospital, 20502 Malmö

Phone: +46+402712660

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07309601

Sponsor: Region Skane

Phase: Not Applicable

Status: Recruiting

Condition: Irritable Bowel Syndrome

Trial contact: +46+402712660

More information: https://clinicaltrials.gov/study/NCT07309601

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who have been diagnosed with irritable bowel syndrome (IBS)
People who have already had genetic testing related to genes that control the production of certain digestive enzymes (called sucrase-isomaltase), as part of a previous study involving a low-starch and low-sugar diet (called SSRD) or a related multi-centre study

Who may not be able to join:

People who have been diagnosed with inflammatory bowel disease, coeliac disease, bile salt malabsorption, gastroenteritis, or problems with how the gut moves food through the body
People who have a severe food allergy
People who have a serious heart, lung, cardiovascular, or mental health condition, or a serious illness such as cancer
People who currently have an eating disorder
People who are pregnant
People who have recently had major surgery on their digestive system
People who have an addiction to alcohol or drugs

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Region Skane

Registry

ClinicalTrials.gov

Start date

1 February 2026

Est. completion

1 February 2028

Where this trial is recruiting

🇸🇪 Sweden

Primary endpoints

Changes of blood glucose after a meal intake

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov